|
MICB expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.743800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.913600E-01 |
| Normal-vs-Stage2 |
6.748100E-02 |
| Normal-vs-Stage3 |
4.504400E-01 |
| Normal-vs-Stage4 |
4.089400E-01 |
| Stage1-vs-Stage2 |
2.46269999999438E-05 |
| Stage1-vs-Stage3 |
8.033800E-01 |
| Stage1-vs-Stage4 |
9.639200E-01 |
| Stage2-vs-Stage3 |
8.245800E-04 |
| Stage2-vs-Stage4 |
2.637400E-03 |
| Stage3-vs-Stage4 |
8.317600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.368000E-01 |
| Normal-vs-AfricanAmerican |
6.766400E-01 |
| Normal-vs-Asian |
4.534200E-01 |
| Caucasian-vs-AfricanAmerican |
7.412000E-01 |
| Caucasian-vs-Asian |
8.923400E-01 |
| AfricanAmerican-vs-Asian |
8.441400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.757800E-01 |
| Normal-vs-Female |
5.119000E-01 |
| Male-vs-Female |
7.851800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.650800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.025400E-01 |
| Normal-vs-Age(61-80Yrs) |
9.957800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.074000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.666390E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.521630E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.581200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.130000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.300430E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.320170E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.201800E-01 |
| Classical-VS-Follicular |
1.62436730732907E-12 |
| Classical-VS-Other |
4.319600E-01 |
| Classical-VS-Normal |
1.090650E-01 |
| Tall-VS-Follicular |
1.15739999806408E-08 |
| Tall-VS-Other |
1.347550E-01 |
| Tall-VS-Normal |
3.655800E-02 |
| Follicular-VS-Other |
2.232000E-01 |
| Follicular-VS-Normal |
3.244100E-03 |
| Other-VS-Normal |
9.229400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.764800E-01 |
| Normal-vs-N1 |
5.239000E-01 |
| N0-vs-N1 |
2.613200E-01 |
|
|
